These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 17414958

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Update on cytokines in rheumatoid arthritis.
    Brennan F, Beech J.
    Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
    [Abstract] [Full Text] [Related]

  • 3. Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance.
    Szekanecz Z, Szegedi G, Koch AE.
    J Investig Med; 1998 Feb; 46(2):27-41. PubMed ID: 9549225
    [Abstract] [Full Text] [Related]

  • 4. [Understanding rheumatoid arthritis].
    Sibilia J, Sordet C, Mrabet D, Wachsmann D.
    Rev Prat; 2005 Dec 15; 55(19):2134-42. PubMed ID: 16544924
    [Abstract] [Full Text] [Related]

  • 5. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
    Chen X, Oppenheim JJ, Howard OM.
    Cell Mol Immunol; 2004 Oct 15; 1(5):336-42. PubMed ID: 16285892
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.
    Iwamoto T, Okamoto H, Toyama Y, Momohara S.
    FEBS J; 2008 Sep 15; 275(18):4448-55. PubMed ID: 18662305
    [Abstract] [Full Text] [Related]

  • 8. Bibliography. Current World Literature. Rheumatoid arthritis.
    Curr Opin Rheumatol; 2007 May 15; 19(3):319-31. PubMed ID: 17489150
    [No Abstract] [Full Text] [Related]

  • 9. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
    Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, Boumans M, Lutter R, Tak PP, Baeten D.
    Arthritis Rheum; 2009 Apr 15; 60(4):966-75. PubMed ID: 19333931
    [Abstract] [Full Text] [Related]

  • 10. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E, Rauchhaus U, Stavropoulos A, Endert G, Wendisch V, Benahmed AS, Giaglis S, Karras J, Lee S, Gaus H, Bennett CF, Williams RO, Sideras P, Panzner S.
    Arthritis Rheum; 2009 Apr 15; 60(4):994-1005. PubMed ID: 19333921
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Chemokines, a new family of cytokines in inflammatory cell recruitment].
    Martínez Martínez CM, Hernández Pando R.
    Rev Invest Clin; 1999 Apr 15; 51(4):255-68. PubMed ID: 10546507
    [Abstract] [Full Text] [Related]

  • 13. Chemokines and their receptors in rheumatoid arthritis: future targets?
    Koch AE.
    Arthritis Rheum; 2005 Mar 15; 52(3):710-21. PubMed ID: 15751074
    [No Abstract] [Full Text] [Related]

  • 14. Development of an ex vivo cellular model of rheumatoid arthritis: critical role of CD14-positive monocyte/macrophages in the development of pannus tissue.
    Nozaki T, Takahashi K, Ishii O, Endo S, Hioki K, Mori T, Kikukawa T, Boumpas DT, Ozaki S, Yamada H.
    Arthritis Rheum; 2007 Sep 15; 56(9):2875-85. PubMed ID: 17763413
    [Abstract] [Full Text] [Related]

  • 15. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.
    Szekanecz Z, Koch AE, Tak PP.
    Neth J Med; 2011 Sep 15; 69(9):356-66. PubMed ID: 21978977
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting.
    Veale DJ, Fearon U.
    Best Pract Res Clin Rheumatol; 2006 Oct 15; 20(5):941-7. PubMed ID: 16980216
    [Abstract] [Full Text] [Related]

  • 17. The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis.
    Santos LL, Morand EF.
    Wien Med Wochenschr; 2006 Jan 15; 156(1-2):11-8. PubMed ID: 16465610
    [Abstract] [Full Text] [Related]

  • 18. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.
    Arthritis Rheum; 2009 Apr 15; 60(4):1006-19. PubMed ID: 19333946
    [Abstract] [Full Text] [Related]

  • 19. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation.
    Jacques C, Gosset M, Berenbaum F, Gabay C.
    Vitam Horm; 2006 Apr 15; 74():371-403. PubMed ID: 17027524
    [Abstract] [Full Text] [Related]

  • 20. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.
    Haringman JJ, Oostendorp RL, Tak PP.
    Expert Opin Emerg Drugs; 2005 May 15; 10(2):299-310. PubMed ID: 15934868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.